الفهرس 
AcknowledgmentOnly 14 pages are availabe for public view
 |  | from | 125 |  |  |
| | | from | 125 | | |
Abstract
Topical 0.03% Tacrolimus is capable of significantly managing symptomatic OLP lesions over 4 week period.
• Topical 0.03% Tacrolimus is as equally efficient in the control of OLP as 0.1 % triamcinolone acetonide.
• Topical 0.03% Tacrolimus can be considered a successful alternative for topical corticosteroids in the management of OLP lesions and in patients where corticosteroids are contraindicated